Patient Acceptance of and Satisfaction with Vasoactive Intracavernous Pharmacotherapy for Impotence

Abstract

Patient acceptance of and satisfaction with a trial of vasoactive intracavernous pharmacotherapy for importence among 372 men were retrospectively analyzed. Drop out from the dosage determination phase and the training for injection phase was similar, 9.7 and 8.4 percent, respectively, while 31.4 percent of the patients dropped out of the home injection phase. Tachyphylaxis, inconvenience of the procedure for the frequent followup visits required, side effects and concern about unknown long-term effects were the main reasons patients cited for dropping out of the trial. The degree of satisfaction among patients who entered the home injection phase was high. Only 55 patients who dropped out of the trial chose implantation of a penile prosthesis. Vasoactive intacavernous pharmacotherapy is an effective treatment of impotence of various etiologies, and in a carefully selected group of patients the acceptance of and satisfaction wiht this therapy are high.